Agenus to Participate in Leerink Partners Global Biopharma Conference
Agenus Inc. (AGEN) announces Dr. Garo Armen, Chairman and CEO, to participate in fireside chat and investor meetings at Leerink Global Biopharma Conference. Webcast available on company's website.
02/26/2024 - 07:30 AM
LEXINGTON, Mass. --(BUSINESS WIRE)--
Agenus Inc. (“Agenus”) (Nasdaq: AGEN), a leader in discovering and developing novel immunological agents to treat various cancers, today announced that Dr. Garo Armen, Chairman and CEO, will participate in a fireside chat and investor one-on-ones at the upcoming Leerink Global Biopharma Conference on March 11th - 13th in Miami Beach, Florida . The fireside chat will take place at 2:30 p.m. ET on March 11th .
A live webcast and replay of the fireside chat will be accessible on the company’s website at https://investor.agenusbio.com/events-and-presentations .
About Agenus
Agenus is a leading immuno-oncology company targeting cancer and infectious diseases with a comprehensive pipeline of immunological agents. The company’s mission is to expand patient populations benefiting from cancer immunotherapy through combination approaches, using a broad repertoire of antibody therapeutics, adoptive cell therapies (through MiNK Therapeutics) and adjuvants (through SaponiQx). Agenus is headquartered in Lexington, MA. For more information, visit www.agenusbio.com or @agenus_bio . Information that may be important to investors will be routinely posted on our website and social media channels.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240226680978/en/
Investors
investor@agenusbio.com
Media
communications@agenusbio.com
Source: Agenus Inc.
When is Dr. Garo Armen participating in the fireside chat?
Dr. Garo Armen will participate in the fireside chat at 2:30 p.m. ET on March 11th.
Where will the Leerink Global Biopharma Conference take place?
The conference will be held in Miami Beach, Florida.
How can investors access the webcast of the fireside chat?
Investors can access the live webcast and replay on Agenus Inc.'s website at https://investor.agenusbio.com/events-and-presentations.
AGEN Rankings
#5098 Ranked by Stock Gains
AGEN Stock Data
Industry
Biological Product (except Diagnostic) Manufacturing
Sector
Manufacturing
Tags
Health Technology, Biotechnology, Manufacturing, Biological Product (except Diagnostic) Manufacturing
Country
US
City
Lexington
About AGEN
agenus is an immunology company discovering and developing novel checkpoint modulators, vaccines and adjuvants to treat cancer and other diseases. we are a dedicated group of scientists, researchers, biotechnologists, physicians, and businesspeople working together toward one goal: to discover and develop therapies that can unleash the innate power of the body’s immune system to treat and potentially cure hard-to-treat cancers and other diseases. our product candidates are designed to work by educating and activating the body’s immune system for a precise and potent attack on cancer. our strategy is to help unlock the potential of one of the most exciting breakthrough areas in cancer treatment in decades, and to develop single agent and combination immune-oncology therapies that can help save lives. our approaches are driven by three platform technologies, including: • our antibody platforms, including our proprietary retrocyte display™ and secant® technologies, and our antibody
